Current approach to the management of psoriatic arthritis according to a sample of Italian rheumatologists.

Abstract:

OBJECTIVES:The purpose of this study was to have an overview of the current approach to psoriatic arthritis (PsA) by a group of Italian rheumatologists. METHODS:Rheumatologists from all around Italy were asked to participate in a survey to give their opinion on a number of statements made by a panel of rheumatologists who are experts in PsA. The survey was conducted through two rounds using a Delphi-like method. The two rounds yielded a consensus on the management of PsA. RESULTS:Fifty rheumatologist from 50 rheumatology centres participated in the survey. Of the 117 proposed statements, only 10 did not reach the 66% concordance threshold. The main results of the survey were that diagnosis of PsA should be made using both the CASPAR criteria and clinical judgment, that all of the features of the psoriatic disease are relevant in the assessment and therapy of PsA, that treatment recommendations are taken into account, that all of the available biological agents may be used in bio-naïve patients, that anti-drug antibody testing is still not used in daily practice, that both switching or swapping are useful options in the case of bio-failure because of lack or loss of efficacy, and that swapping is considered the best choice in the case of bio-failure due to adverse events. CONCLUSIONS:The results of this survey showed that a comprehensive evaluation of the patient and a therapy choice based on both patient clinical features and evidence of drug efficacy and safety are considered the current best of care for PsA patients.

journal_name

Clin Exp Rheumatol

authors

Marchesoni A,Lubrano E,Manara M,Ramonda R,Salvarani C,Olivieri I

subject

Has Abstract

pub_date

2016-11-01 00:00:00

pages

1051-1058

issue

6

eissn

0392-856X

issn

1593-098X

pii

10395

journal_volume

34

pub_type

杂志文章
  • Rheumatoid vasculitis presenting as appendicitis.

    abstract::Appendicitis was diagnosed in a 38-year-old patient with seropositive rheumatoid arthritis. Despite appendectomy the patient's clinical condition deteriorated. Thorough microscopical evaluation of the pathological anatomical specimens from the appendix made possible a diagnosis of necrotizing vasculitis. The systemic ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: van Laar JM,Smit VT,de Beus WM,Collée G,Jansen EH,Breedveld FC

    更新日期:1998-11-01 00:00:00

  • Ultrasound assessment of the posterior sacroiliac ligaments.

    abstract:OBJECTIVES:Posterior ligaments of the sacroiliac joints (SIJ) are comprised of the long and the short posterior sacroiliac ligaments. They are recognised as a potential source of aspecific low back pain or peripartum pelvic pain. The aim of this study was to assess the characteristics of these ligaments using high reso...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Le Goff B,Berthelot JM,Maugars Y

    更新日期:2011-11-01 00:00:00

  • Pneumococcal septic arthritis as the first manifestation of multiple myeloma.

    abstract::In this paper we report a 47 year old woman with septic arthritis due to Streptococcus pneumoniae. No known predisposing factor was found. After an extensive workup a multiple myeloma was discovered. In our case septic arthritis was the first manifestation of multiple myeloma. ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Cuesta M,Bernad M,Espinosa A,Herranz P,Martin Mola E,Gijón Baños J

    更新日期:1992-09-01 00:00:00

  • Association study of the platelet collagen receptor glycoprotein VI gene with rheumatoid arthritis.

    abstract:OBJECTIVES:Beyond their role in haemostasis, platelets can actively contribute to immunity. The activation of the platelet collagen receptor glycoprotein VI (GPVI) promotes the release of small extracellular vesicles called microparticles. These microparticles are found in the joint bathing fluid of patients with rheum...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Michou L,Cornélis F,Baron M,Bombardieri S,Balsa A,Westhovens R,Barrera P,Alves H,Radstake TR,Migliorini P,Bardin T,Petit-Teixeira E,Boilard E

    更新日期:2013-09-01 00:00:00

  • Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.

    abstract::Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to conventional immunosuppressive treatment. However, some patients fail to respond even to TNF-α blockers. Interleukin-6 (IL-6) is a key player in the pathogenesis of TA. Preliminary data also suggest efficacy of the IL-6 recept...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Salvarani C,Magnani L,Catanoso MG,Pipitone N,Versari A,Dardani L,Pulsatelli L,Meliconi R,Boiardi L

    更新日期:2012-01-01 00:00:00

  • Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatment.

    abstract:BACKGROUND:Adipose tissue-derived leptin and adiponectin control hunger, energy expenditure, insulin sensitivity, endothelial function, reproduction and immunity and are thought to play a role in autoimmune diseases. However, their role in ankylosing spondylitis (AS) is not clearly defined. Tumour necrosis factor ΤNF-α...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Derdemezis CS,Filippatos TD,Voulgari PV,Tselepis AD,Drosos AA,Kiortsis DN

    更新日期:2010-11-01 00:00:00

  • Consideration of coping strategies for patients suffering from systemic lupus erythematosus: reflection for a personalised practice of patient education.

    abstract:OBJECTIVES:Systemic lupus erythematosus (SLE) is a chronic autoimmune multi-organ disease with an unpredictable course. SLE causes functional disability, changes in body appearance, and psychological distress. When faced with SLE, patients have to implement coping strategies. Therefore, the aim of this study was to des...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Farhat MM,Morell-Dubois S,Le Gouellec N,Launay D,Maillard H,Balquet MH,Azar R,Quemeneur T,Boldron A,Bataille P,Lambert M,Lanteri A,Buchdahl AL,Sobanski V,Hatron PY,Hachulla E,Clerson P,ESSTIM Investigators group.

    更新日期:2020-07-01 00:00:00

  • Protease inhibitors in rheumatoid synovial fluid: a quantitative analysis.

    abstract::The concentrations of the main endogenous inhibitors of granulocyte proteases (anti-leukoprotease, alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin) were estimated in paired samples of synovial fluid and serum/plasma from seropositive rheumatoid arthritics and controls. Rheumatoid synovial flui...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Ekerot L,Sjöblom KG,Ohlsson K,Wollheim FA

    更新日期:1983-07-01 00:00:00

  • The enthesis in psoriatic arthritis.

    abstract::In recent years the argument that enthesitis is the primary lesion in many or most patients with psoriatic arthritis and spondyloarthritis has gained further credence from animal models including IL23/IL17 axis and TNF dependent models. The role of joint biomechanics at entheses and other sites of high physical stress...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: McGonagle D,Tan AL

    更新日期:2015-09-01 00:00:00

  • Expression of inflammasomes NLRP1, NLRP3 and AIM2 in different pathologic classification of lupus nephritis.

    abstract:OBJECTIVES:Lupus nephritis (LN) is an immune-complex mediated nephritis with complicated pathogenesis. The aims of the present study were to investigate whether inflammasomes are activated in the renal pathology of LN patients and analyse the association of inflammasome activation in different classes of LN renal tissu...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Huang T,Yin H,Ning W,Wang X,Chen C,Lin W,Li J,Zhou Y,Peng Y,Wang M,Ni X,Zhang W

    更新日期:2020-07-01 00:00:00

  • Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.

    abstract:OBJECTIVES:To study the CD26 density on monocytes and CD4+ T-lymphocytes in steroid and DMARD-naïve, early rheumatoid arthritis (RA) patients and to analyse for correlations with disease activity, including long-term radiographic progression. METHODS:Forty patients with active, early steroid and DMARD naïve RA (<6 mon...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,随机对照试验

    doi:

    authors: Ellingsen T,Hansen I,Thorsen J,Kuno Møller B,Tarp U,Jacobsen S,Lund Hetland M,Vestergaard A,Hørslev-Petersen K,Stengaard-Pedersen K

    更新日期:2012-01-01 00:00:00

  • Clinical features, scintiscan characteristics and X-ray progression of late onset rheumatoid arthritis.

    abstract::The clinical features, serology behaviour, scintiscan characteristics and the degree of X-ray progression according to the disease duration were compared in two RA groups with a disease onset after 65 years of age (LORA) and before 65 (EORA) respectively. No differences emerged in either the clinical findings or in th...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Ferraccioli GF,Cavalieri F,Mercadanti M,Conti G,Viviano P,Ambanelli U

    更新日期:1984-04-01 00:00:00

  • Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.

    abstract:OBJECTIVES:Anti-cyclic citrullinated peptide antibodies (anti-CCP) are a serological marker of rheumatoid arthritis (RA), and also have a prognostic value for more aggressive disease. Whether anti-CCP levels may change during treatment according to clinical response is matter of debate. Likewise, it is unknown whether ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Iannone F,Tampoia M,Giannini M,Lopalco G,Cantarini L,Villalta CD,Galeazzi M,Lapadula G

    更新日期:2016-05-01 00:00:00

  • Adherence to guidelines for the treatment of Behçet's syndrome in New York and Amsterdam.

    abstract:OBJECTIVES:To assess adherence to published guidelines for the treatment of Behçet's syndrome (BS) in two geographic areas. METHODS:We extracted guideline statements from the 2008 EULAR recommendations. Adherence to these statements was evaluated retrospectively in both New York (USA) and Amsterdam (The Netherlands), ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Kerstens FG,Turkstra F,Atalay S,van Vugt RM,Swearingen CJ,Yazici Y

    更新日期:2017-11-01 00:00:00

  • Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire.

    abstract:OBJECTIVE:To evaluate an existing tool (the Swedish modification of the Psoriasis Assessment Questionnaire) and to develop a new instrument to screen for psoriatic arthritis in people with psoriasis. DESIGN:The starting point was a community-based survey of people with psoriasis using questionnaires developed from the...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Ibrahim GH,Buch MH,Lawson C,Waxman R,Helliwell PS

    更新日期:2009-05-01 00:00:00

  • COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

    abstract::A severe outbreak of coronavirus disease 2019 (COVID-19) emerged in China in December 2019, and spread so rapidly that more than 200,000 cases have so far been reported worldwide; on January 30, 2020, the WHO declared it the sixth public health emergency of international concern. The two previously reported coronaviru...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Sarzi-Puttini P,Giorgi V,Sirotti S,Marotto D,Ardizzone S,Rizzardini G,Antinori S,Galli M

    更新日期:2020-03-01 00:00:00

  • Intravenous cyclophosphamide therapy for systemic sclerosis. A single-center experience and review of the literature with pooled analysis of lung function test results.

    abstract:OBJECTIVE:Oral cyclophosphamide (CYC) is a promising therapy for Systemic Sclerosis (SSc)-related interstitial lung disease (ILD). The use of intravenous (i.v.) pulses has been considered as an alternative route of drug administration, possibly associated with reduced toxicity. Our objectives were to re-evaluate our ex...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Airò P,Danieli E,Parrinello G,Antonioli CM,Cavazzana I,Toniati P,Franceschini F,Cattaneo R

    更新日期:2004-09-01 00:00:00

  • Ultrasound imaging for the rheumatologist. XLII. Assessment of hip pain in rheumatic patients: the radiologist's view.

    abstract::Hip pain is a common complaint in daily practice and the identification of the underlying pathologic condition is the first step for an adequate treatment. In this review, we discuss the available evidence for the application of conventional radiography, computed tomography and magnetic resonance imaging in rheumatolo...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Vitali S,Delle Sedie A,Filippucci E,Riente L,Iagnocco A,Sakellariou G,Meenagh G,Paolicchi A,Montecucco C,Valesini G,Grassi W,Bombardieri S,Caramella D

    更新日期:2012-11-01 00:00:00

  • Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.

    abstract:OBJECTIVES:The superiority of true drug treatment over placebo in reducing symptoms of fibromyalgia syndrome (FMS) is small and bought by relevant rates of drop-outs due to adverse events. Recent systematic reviews demonstrated that a substantial proportion of the beneficial and adverse effects of true drug is attribut...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,meta分析,评审

    doi:

    authors: Häuser W,Sarzi-Puttini P,Tölle TR,Wolfe F

    更新日期:2012-11-01 00:00:00

  • Signalling in inflammatory skin disease by AP-1 (Fos/Jun).

    abstract::Skin inflammation is a physiological reaction to tissue injury, pathogen invasion and irritants. During this process, innate and/or adaptive immune cells are activated and recruited to the site of inflammation to either promote or suppress inflammation. The sequential recruitment and activation of immune cells is modu...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Uluçkan Ö,Guinea-Viniegra J,Jimenez M,Wagner EF

    更新日期:2015-07-01 00:00:00

  • Low dose etanercept treatment for maintenance of clinical remission in ankylosing spondylitis.

    abstract:OBJECTIVES:To investigate the efficacy and safety of low-dose etanercept treatment after clinical remission of ankylosing spondylitis (AS) in the real world. METHODS:Data on 134 AS patients who were treated with etanercept for more than 12 months and achieved clinical remission (BASDAI<4 and CRP<0.5 mg/dL) were extrac...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Park JW,Yoon YI,Lee JH,Park JK,Lee EB,Song YW,Lee EY

    更新日期:2016-07-01 00:00:00

  • Epilepsy in systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is an autoimmune systemic disease characterised by a broad spectrum of clinical manifestations that may also affect the central nervous system. Among the neurological symptoms, seizures were included in the criteria for the classification of SLE published by EULAR/ACR in 2019. Severa...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Grasso EA,Cacciatore M,Gentile C,Breda L,Giacomelli R,Verrotti A

    更新日期:2020-09-04 00:00:00

  • Corticotropin releasing hormone promoter polymorphisms in giant cell arteritis and polymyalgia rheumatica.

    abstract:OBJECTIVE:Giant cell (temporal) arteritis (GCA) and polymyalgia rheumatica (PMR) are different but overlapping diseases of unknown etiology affecting the elderly. Corticotropin-releasing hormone (CRH) helps to regulate the immune response and maintain homeostasis during inflammatory stress. CRH promoter region polymorp...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Gonzalez-Gay MA,Hajeer AH,Dababneh A,Garcia-Porrua C,Amoli MM,Thomson W,Ollier WE

    更新日期:2002-03-01 00:00:00

  • Reliability, validity and responsiveness of instruments to assess disabilities in personal care in patients with rheumatic disorders. A systematic review.

    abstract:OBJECTIVES:The first aim was to make an inventory of available instruments and questionnaires for the assessment of disabilities in personal care in patients with rheumatic disorders. The second aim was to investigate which of these instruments have acceptable, methodological quality with regard to reliability, validit...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Swinkels RA,Dijkstra PU,Bouter LM

    更新日期:2005-01-01 00:00:00

  • Can remission be maintained with or without further drug therapy in rheumatoid arthritis?

    abstract::Remission is now the accepted goal of management in rheumatoid arthritis (RA). This article highlights the controversies surrounding the definition of remission and reviews the potential of current treatment options to achieve remission. Defining "true" remission can be difficult based on current criteria, which do no...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Saleem B,Nizam S,Emery P

    更新日期:2006-11-01 00:00:00

  • Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factors.

    abstract:OBJECTIVES:Patients with clinically evident autoimmune disease are at increased risk for premature cardiovascular disease (CVD). Markers of serological autoimmunity such as anti-nuclear antibodies (ANA) are found in approximately 25% of the general population. Yet, the vast majority will not develop clinical autoimmune...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Solow EB,Vongpatanasin W,Skaug B,Karp DR,Ayers C,de Lemos JA

    更新日期:2018-11-01 00:00:00

  • Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates.

    abstract::A young woman with transient osteoporosis of the hip (TOH) during pregnancy, severe pain, physical disability and marked generalized osteoporosis was treated with intravenous biphosphonates with prompt beneficial effects on both clinical symptoms and bone density. The features of this rare and sometimes underdiagnosed...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Schapira D,Braun Moscovici Y,Gutierrez G,Nahir AM

    更新日期:2003-01-01 00:00:00

  • Monotherapy is a relevant option in rheumatoid arthritis treatment: a literature review.

    abstract::The latest revision of the European League Against Rheumatism (EULAR) recommendations for rheumatoid arthritis (RA) treatment maintains the indication for the combined therapy of biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs), namely Jak-inhibitors as tofacitinib an...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Doria A,Zavaglia D

    更新日期:2019-09-01 00:00:00

  • Body mass index and persistence of conventional DMARDs and TNF inhibitors in rheumatoid arthritis.

    abstract:OBJECTIVES:Obese patients with rheumatoid arthritis (RA) may be more likely to discontinue therapy than non-obese patients, possibly signifying a more refractory phenotype. The purpose of this study was to examine the association between body mass index (BMI) and discontinuation rates for different RA treatments accoun...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: McCulley CB,Barton JL,Cannon GW,Sauer BC,Teng CC,George MD,Caplan L,England BR,Mikuls TR,Baker JF

    更新日期:2019-05-01 00:00:00

  • Long-term results of the FIN-RACo trial; treatment with a combination of traditional disease-modifying anti-rheumatic drugs is an excellent option in early rheumatoid arthritis.

    abstract::The Finnish Rheumatoid Arthritis Combination Therapy Trial (FIN-RACo) started in 1993, in an era of disappointing results in the treatment of rheumatoid arthritis (RA). The FIN-RACo was the first trial aiming at remission and comparing two different treatment strategies: initially triple therapy with compulsory predni...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Rantalaiho V,Puolakka K,Korpela M,Hannonen P,Möttönen T

    更新日期:2012-07-01 00:00:00